268 related articles for article (PubMed ID: 25041592)
1. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have?
Yamamoto M; Pop-Vicas AE
Crit Care; 2014 Jun; 18(3):229. PubMed ID: 25041592
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
Guh AY; Limbago BM; Kallen AJ
Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
[TBL] [Abstract][Full Text] [Related]
3. The emerging threat from carbapenem-resistant enterobacteriaceae.
Landry J; Hurst H
Nurs Womens Health; 2013 Dec; 17(6):519-24. PubMed ID: 24589052
[TBL] [Abstract][Full Text] [Related]
4. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
Brink A; Coetzee J; Clay C; Corcoran C; van Greune J; Deetlefs JD; Nutt L; Feldman C; Richards G; Nordmann P; Poirel L
S Afr Med J; 2012 May; 102(7):599-601. PubMed ID: 22748433
[TBL] [Abstract][Full Text] [Related]
5. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):256-60. PubMed ID: 19300408
[TBL] [Abstract][Full Text] [Related]
6. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital.
Torres-Gonzalez P; Cervera-Hernandez ME; Niembro-Ortega MD; Leal-Vega F; Cruz-Hervert LP; García-García L; Galindo-Fraga A; Martinez-Gamboa A; Bobadilla-Del Valle M; Sifuentes-Osornio J; Ponce-de-Leon A
PLoS One; 2015; 10(10):e0139883. PubMed ID: 26431402
[TBL] [Abstract][Full Text] [Related]
8. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
Martirosov DM; Lodise TP
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review and Meta-analyses of the Clinical Epidemiology of Carbapenem-Resistant Enterobacteriaceae.
van Loon K; Voor In 't Holt AF; Vos MC
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038269
[TBL] [Abstract][Full Text] [Related]
10. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials.
Trivedi M; Patel V; Soman R; Rodriguez C; Singhal T
J Assoc Physicians India; 2012 Aug; 60():28-30. PubMed ID: 23405518
[TBL] [Abstract][Full Text] [Related]
11. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
[TBL] [Abstract][Full Text] [Related]
12. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
Pang F; Jia XQ; Zhao QG; Zhang Y
Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
[TBL] [Abstract][Full Text] [Related]
13. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.
Gupta N; Limbago BM; Patel JB; Kallen AJ
Clin Infect Dis; 2011 Jul; 53(1):60-7. PubMed ID: 21653305
[TBL] [Abstract][Full Text] [Related]
14. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
15. The management of multidrug-resistant Enterobacteriaceae.
Bassetti M; Peghin M; Pecori D
Curr Opin Infect Dis; 2016 Dec; 29(6):583-594. PubMed ID: 27584587
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
[TBL] [Abstract][Full Text] [Related]
17. Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy.
Ma J; Song X; Li M; Yu Z; Cheng W; Yu Z; Zhang W; Zhang Y; Shen A; Sun H; Li L
Microbiol Res; 2023 Jan; 266():127249. PubMed ID: 36356348
[TBL] [Abstract][Full Text] [Related]
18. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose.
Savard P; Perl TM
Clin Microbiol Infect; 2014 Sep; 20(9):854-61. PubMed ID: 24980472
[TBL] [Abstract][Full Text] [Related]
19. Carbapenem-resistant Enterobacteriaceae: biology, epidemiology, and management.
Temkin E; Adler A; Lerner A; Carmeli Y
Ann N Y Acad Sci; 2014 Sep; 1323():22-42. PubMed ID: 25195939
[TBL] [Abstract][Full Text] [Related]
20. Proactive infection control measures to prevent nosocomial transmission of carbapenem-resistant Enterobacteriaceae in a non-endemic area.
Cheng VC; Chan JF; Wong SC; Chen JH; Tai JW; Yan MK; Kwan GS; Tse H; To KK; Ho PL; Yuen KY
Chin Med J (Engl); 2013 Dec; 126(23):4504-9. PubMed ID: 24286415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
